A Database of Breast Oncogenic Specific SiRNAs

Overview

Journal Sci Rep

Specialty Science

Date 2017 Aug 20

PMID 28821760

Authors

Atul Tyagi

Manoj Semwal

Ashok Sharma

Affiliations

Soon will be listed here.

Abstract

Breast cancer is a serious problem causing the death of women across the world. At present, one of the major challenges is to design drugs to target breast cancer specific gene(s). RNA interference (RNAi) is an important technique for targeted gene silencing that may lead to promising novel therapeutic strategies for breast cancer. Therefore, identification of such molecules having high oncogene specificity is the need of the hour. Here, we have developed a database named as Breast Oncogenic Specific siRNAs (BOSS, http://bioinformatics.cimap.res.in/sharma/boss/ ) on the basis of the current research status on siRNA-mediated repression of oncogenes in different breast cancer cell lines. BOSS is a resource of experimentally validated breast oncogenic siRNAs, collected from research articles and patents published yet. The present database contains information on 865 breast oncogenic siRNA entries. Each entry provides comprehensive information of an siRNA that includes its name, sequence, target gene, type of cells, and inhibition value, etc. Additionally, some useful tools like siRNAMAP and BOSS BLAST were also developed and linked with the database. siRNAMAP can be used for the selection of best siRNA against a target gene while BOSS BLAST tool helps to locate the siRNA sequences in deferent oncogenes.

References

Elbashir S, Harborth J, Weber K, Tuschl T . Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002; 26(2):199-213. DOI: 10.1016/S1046-2023(02)00023-3. View

Howlin J, Rosenkvist J, Andersson T . TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res. 2008; 10(2):R36. PMC: 2397538. DOI: 10.1186/bcr2087. View

Dash R, Moharana S, Reddy A, Sastry G, Sastry G . DSTHO: database of siRNAs targeted at human oncogenes: a statistical analysis. Int J Biol Macromol. 2006; 38(1):65-9. DOI: 10.1016/j.ijbiomac.2005.12.024. View

Qin B, Cheng K . Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells. Breast Cancer Res. 2010; 12(5):R74. PMC: 3096963. DOI: 10.1186/bcr2644. View

Truss M, Swat M, Kielbasa S, Schafer R, Herzel H, Hagemeier C . HuSiDa--the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells. Nucleic Acids Res. 2004; 33(Database issue):D108-11. PMC: 540085. DOI: 10.1093/nar/gki131. View

Tyagi A, Ahmed F, Thakur N, Sharma A, Raghava G, Kumar M . HIVsirDB: a database of HIV inhibiting siRNAs. PLoS One. 2011; 6(10):e25917. PMC: 3191155. DOI: 10.1371/journal.pone.0025917. View

Kumar R, Conklin D, Mittal V . High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 2003; 13(10):2333-40. PMC: 403718. DOI: 10.1101/gr.1575003. View

Ren Y, Gong W, Zhou H, Wang Y, Xiao F, Li T . siRecords: a database of mammalian RNAi experiments and efficacies. Nucleic Acids Res. 2008; 37(Database issue):D146-9. PMC: 2686443. DOI: 10.1093/nar/gkn817. View

Pille J, Denoyelle C, Varet J, Bertrand J, Soria J, Opolon P . Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther. 2005; 11(2):267-74. DOI: 10.1016/j.ymthe.2004.08.029. View

10.

Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. DOI: 10.1038/35078107. View

11.

Osborne C, Wilson P, Tripathy D . Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist. 2004; 9(4):361-77. DOI: 10.1634/theoncologist.9-4-361. View

12.

Thakur N, Qureshi A, Kumar M . VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA. Nucleic Acids Res. 2011; 40(Database issue):D230-6. PMC: 3245049. DOI: 10.1093/nar/gkr1147. View

13.

Dressing G, Alyea R, Pang Y, Thomas P . Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm Cancer. 2012; 3(3):101-12. PMC: 10358000. DOI: 10.1007/s12672-012-0106-x. View

14.

Abdelrahim M, Smith 3rd R, Safe S . Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol. 2003; 63(6):1373-81. DOI: 10.1124/mol.63.6.1373. View

15.

Timmons L, Fire A . Specific interference by ingested dsRNA. Nature. 1998; 395(6705):854. DOI: 10.1038/27579. View

16.

Qiao H, Wang T, Yan W, Qin A, Fan Q, Han X . Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro. Acta Pharmacol Sin. 2015; 36(9):1085-98. PMC: 4561967. DOI: 10.1038/aps.2015.42. View

17.

Chalk A, Warfinge R, Georgii-Hemming P, Sonnhammer E . siRNAdb: a database of siRNA sequences. Nucleic Acids Res. 2004; 33(Database issue):D131-4. PMC: 540090. DOI: 10.1093/nar/gki136. View

18.

Gong W, Ren Y, Xu Q, Wang Y, Lin D, Zhou H . Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics. 2006; 7:516. PMC: 1698580. DOI: 10.1186/1471-2105-7-516. View

19.

Dar S, Thakur A, Qureshi A, Kumar M . siRNAmod: A database of experimentally validated chemically modified siRNAs. Sci Rep. 2016; 6:20031. PMC: 4730238. DOI: 10.1038/srep20031. View

20.

Liang Y, Gao H, Lin S, Goss J, Brunicardi F, Li K . siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS One. 2010; 5(9):e12860. PMC: 2942895. DOI: 10.1371/journal.pone.0012860. View